drugset / Trial / NCT03886324

POISE I Pilot Study

NCT03886324

Unknown 10 enrolled GIE Medical
NaSingle-groupOpen-labelTreatment

Summary

POISE I study is a feasibility study for evaluating the safety and efficacy of DCB.

Timeline

Start
2019-02-25
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule